Clinical Trials Browser

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT07436858 2026-02-27

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

Phase 1 Not yet recruiting

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05737615 2025-09-04

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT07114627 2025-08-11

ESCAPE

Recruiting

66 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Hand-Foot Syndrome

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

12 enrolled

Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT02120222 2023-04-04

KPT-330

Phase 1 Completed

8 enrolled

Dermatologic

Melanoma

NCT01855061 2018-03-09

CPCT-01

Terminated

79 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT00989586 2017-02-06

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 1/2 Completed

35 enrolled 11 charts

Lymphoid

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00323323 2017-01-20

CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas